Key Market Drivers
- Increasing Cases of Atrial Fibrillation (AF) Globally
Atrial fibrillation is the most frequent heart arrhythmia. It is a prevalent heart rhythm abnormality in the 21st century, causing cardiovascular disease (CVD) epidemics. AF leads to higher morbidity and mortality rates, straining healthcare systems. Proper intervention and prompt identification can reduce AF-related problems. Implantable pacemakers and defibrillators are designed to detect and treat moderate to severe arrhythmias in people.
- Potential Applications of Microelectronic Medical Implants
Microelectronic medical implants are designed for a wide range of applications. These products are advanced with Bluetooth technology, recharge-free devices, and various applications that warn patients about their health issues and connect them with their physicians. Medical devices have undergone substantial evolution in this era of digitalization, becoming the most promising tools for cardiovascular, neurological, and other applications.
- Increasing Use of Microelectronic Medical Implants
Microelectronic medical implant technologies are increasingly used to manage chronic diseases. Implantable devices have improved the quality of life and outcomes for patients with previously untreatable conditions, reduced the adverse effects of current therapy, and slowed or halted disease progression.
- Growing Global Elderly Population
Older people are more prone to suffer from chronic ailments such as neurodegenerative disorders, CVDs, musculoskeletal disorders, and other diseases. According to the National Council on Aging, 80% of older people have at least one chronic disease, and 77% are afflicted with at least two chronic diseases. One in every four older adults experiences mental disorders, including depression, anxiety disorders, and dementia. The prevalence is expected to double to 15 million by the end of 2030.
Microelectronic Medical Implants – By Product Type
The global market for microelectronic medical implants is divided into pacemakers, defibrillators, neurostimulators, hearing implants, and ocular implants.
- Pacemakers - A pacemaker is a cardiac device that listens to the heart and waits for the heart to beat in response to an indicator from the heart's electrical system. It is typically recommended for patients with bradycardia, a cardiac rhythm abnormality, as the pacemaker signals for replacement when the heart's system fails to pick up the signal. Many major companies offer pacemakers.
One such company is Abbott, whose Aveir line of leadless pacemakers includes the Aveir AR atrial pacemaker, the Avier VR ventricular pacemaker, and the Aveir DR dual chamber pacemaker system.
- Defibrillators - A defibrillator utilizes electrical energy to shock the heart. It is typically used to treat cardiac arrest, which can lead to ventricular fibrillation and ventricular tachycardia, potentially fatal arrhythmias caused by abnormal ventricle contraction. Defibrillators are equipped with adhesive patches and ECG leads, known as adhesive electrodes, to administer the shock. Defibrillators have three characteristics: a direct current power source, a capacitor charged to a preset energy level, and two electrodes applied to the patient's chest.
Boston Scientific is one company offering defibrillators. ICDs include the Dynagen Mini ICD, the Emblem MRI S-ICD, the Inogen Mini ICD, the Momentum EL ICD, and the Perciva ICD.
- Neurostimulators - Neurostimulators adjust neural activity to treat neurological disorders. These implants send electrical impulses to specific nervous system areas and aid in regulating irregular signals that result in symptoms.
For example, deep brain stimulators (DBS) focus on the brain regions in charge of motor control and are utilized to treat movement disorders such as dystonia, essential tremor, and Parkinson's disease. DBS enhances quality of life by substantially reducing tremors, stiffness, and other motor complaints by modifying electrical impulses.
- Hearing Implants - A cochlear implant is a type of hearing prosthesis intended to compensate for hearing loss in adults and children with severe to profound bilateral sensorineural hearing impairments for which hearing aids are not very helpful. It consists of two parts: one surgically inserted beneath the skin and the other externally placed behind the ear.
Cochlear Ltd. offers two hearing implants: the Cochlear Nucleus and the Cochlear Osia System.
- Ocular Implants - Retinal implants are a new treatment for blindness, restoring vision for patients with age-related macular degeneration and retinitis pigmentosa. These implants avoid injured photoreceptors in the retina, translating light into neurological messages. The most popular type is a multi-component system that captures and processes visual data. It transfers the data wirelessly to an array implanted in the retina, stimulating remaining retinal cells to decipher patterns and create basic images.
Conclusion
The use of microelectronic medical implants will undoubtedly accelerate over the coming decades owing to the increasing number of diseases, the growing geriatric population, and the demand for implantable devices for early diagnosis. Such factors are expected to drive the market for microelectronic medical implants.
Learn More and Take Action:
Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.
Contact us today to find out more.
